How often can I take Tussin (dextromethorphan)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dextromethorphan (Tussin) Dosing Frequency

For adults, dextromethorphan should be taken as 20-30 mg every 4-6 hours, with a maximum daily dose not exceeding 120 mg per day. 1, 2

Standard Dosing Recommendations

Adults

  • Single dose: 20-30 mg 2, 3
  • Frequency: Every 4-6 hours as needed 1
  • Maximum daily dose: 120 mg per day (typically 4 doses of 30 mg) 2
  • Studies demonstrate that a single 30 mg dose provides reproducible cough suppressant effects with objective reduction in cough counts and intensity 2

Pediatric Patients

  • Dextromethorphan has been used safely in children for over 30 years 1
  • The safety profile in pediatric overdose is reassuring, though specific pediatric dosing should follow product labeling 1

Clinical Efficacy Evidence

Dextromethorphan at 20 mg doses has been shown to be as effective as codeine for cough suppression, with superior tolerability. 3

  • In comparative trials, 20 mg dextromethorphan reduced cough frequency similarly to 20 mg codeine 3
  • Dextromethorphan lowered cough intensity significantly more than codeine (p < 0.0008) 3
  • The majority of patients preferred dextromethorphan over codeine (p < 0.001) 3

Safety Considerations

Adverse Effects

  • Adverse drug reactions are infrequent and usually not severe when used at recommended doses 1
  • Dose-related symptoms may include neurological, cardiovascular, and gastrointestinal disturbances 1
  • The drug has a reassuring safety profile, particularly regarding overdose in both adults and children 1

Critical Drug Interactions

Do not use dextromethorphan with monoamine oxidase inhibitors (MAOIs). 1

  • Coadministration of MAOIs and dextromethorphan represents a significant safety concern 1
  • This combination can result in serious adverse events 1

Abuse Potential

  • The most significant hazard identified through adverse event reporting is episodic and sporadic abuse 1
  • Despite this concern, when used appropriately for short-term treatment, dextromethorphan maintains a favorable safety profile 1

Duration of Treatment

  • Dextromethorphan is intended for short-term symptomatic relief of cough 1
  • The pharmacokinetic polymorphism observed with dextromethorphan does not correlate with clinically significant safety risks during short-term use 1
  • Objective cough suppression effects occur within hours of a single dose and persist for the dosing interval 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.